Pharmamar 주식 가격. PHME - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

Pharmamar SA (PHME)

38.16

-1.30

( -3.29% )

업데이트: 22:15:45

실시간 데이터

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

가격

38.16

매수가

38.44

매도가

38.72

거래량

475

37.56 일간 변동폭 38.66

0.00 52주 범위 0.00

전일 종가

39.46

개장가

38.66

최근 거래 시간

마지막 거래 시간

21:27:42

평균 볼륨(3m)

-

재정 규모

18,075 €

VWAP

38.0523

ALX Oncology to Host Investor Call and Webcast to Share Topline Data Results From ASPEN-06 Phase 2 Clinical Trial of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer

Conference Call and Webcast Today at 4:30 PM EDT SOUTH SAN FRANCISCO, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1 ASPEN-07 Clinical Trial in Patients with Advanced Bladder Cancer

Evorpacept in combination with PADCEV®, an approved antibody-drug conjugate (“ADC”), demonstrated promising activity and was generally well toleratedCompany to host conference call and webcast...

ALX Oncology Announces Participation in the Jefferies Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that...

Form 4 - Statement of changes in beneficial ownership of securities

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

가장 활성
% 상승자
% 패자

기호	가격	볼륨
ISOFOSIsofol Medical AB	SEK 2.765 (56.57%)	71.14k
AG1DAUTO1 Group	7.905 € (15.57%)	20.67k
TMVDTeamViewer SE	12.245 € (11.78%)	46.89k
JDEPAJDE Peets NV	20.42 € (10.86%)	74.23k
TKWYAJust Eat Takeaway.com N.V.	11.985 € (10.77%)	212.91k
LOCALPSolocal Groupe	0.0035 € (-35.19%)	11.18M
2HRADH & R GmbH & Co	4.10 € (-18.33%)	197
EBUSAEbusco Holding NV	1.2135 € (-15.26%)	19.67k
VAR1DVarta AG	1.979 € (-15.21%)	31.14k
GSC1DGesco SE	13.45 € (-11.51%)	541
LOCALPSolocal Groupe	0.0035 € (-35.19%)	11.18M
CABKECaixaBank SA	5.304 € (-2.25%)	1.28M
ISPMIntesa Sanpaolo Spa	3.77 € (-0.70%)	1.18M
BBVAEBanco Bilbao Vizcaya Argentaria SA	9.788 € (-3.99%)	1.03M
FINGBSFingerprint Cards AB	SEK 0.0761 (0.00%)	850.08k

georgie18

georgie18 4 분 전

Kyle279

Kyle279 4 분 전

Unfortunately Finra is taking about 6 months these days on name changes

HD2001

HD2001 4 분 전

Not until our CEO finishes dumping

pos_stock_hoarder

pos_stock_hoarder 5 분 전

https://resources.arcamax.com/newspics/300/30008/3000816.gif

WooptdooU

WooptdooU 5 분 전

Hopelessly hopeful pennylongs are Hamstringed by both GREED and FEAR...wow, the GRIFTER, WELFARIST, Baldheaded (his word) and his water cooler crowd are like the communists who stick together with the WRONG and even sinful dialog. Pity, really, that the Dr, Dr offspring think TAKING PEOPLE'S MONEY w

AtlasQ

AtlasQ 5 분 전

No one truly knows. Still taking the risk though

StayHumble

StayHumble 5 분 전

FC:0H W0W,going to $20 S00N now!✅ $DBMM UCLA✅Xerox|Maybach|HR0wen| Savills|AbbeyRoadInst|Santander|Mercedes|Chatsworth|Ernst&Young|Omnisport|PinsentMasons

Facts and Data Speak for Themselves.
Source: https://investorshub.advfn.com/boards/read_msg.aspx?m

Karlchen

Karlchen 5 분 전

HOPE in our case it's different, but in the recent past i have two holdings with approval the price went down and now small sales IBRX IOVA and the sp declines further!
but as i always say, the next years will be great anyway

oystersnbeer

oystersnbeer 5 분 전

Harris plans to campaign with VP pick in battleground states next week, starting in Philadelphia.
Shapiro is her guy.

nfrequent

nfrequent 5 분 전

Jay, do you misread stuff on purpose? The NYSE American accepted the FOXO compliance plan. In other words, the exchange thinks the plan should support a higher stock price without a reverse split. Of course, we all know what the plan involves the share exchange agreement with RNVA. FOXO must be in c

pos_stock_hoarder

pos_stock_hoarder 5 분 전

https://resources.arcamax.com/newspics/300/30008/3000816.gif

Runners123

Runners123 5 분 전

LSH has done it again

timberwolf7

timberwolf7 5 분 전

This is what the commies are happy just happened: Without being smart
enough to KNOW what just happened.

https://media.gab.com/cdn-cgi/image/width=568,quality=100,fit=scale-down/system/media_attachments/files/164/355/991/original/86a3355b23aef856.jpeg

crowin

crowin 6 분 전

Would you like to have a good time too?

fink

So is FINRA.
Thats where this train went off the tracks.
The entire Symbol/Name change took this New Co for an eye opener in the world of OTC.

If they intend to expand and use a 24B A/S over the next decade, then why would they care about a few 100m shares now? The $4

jeffree

jeffree 6 분 전

..."other than THAT"....

The scare-mongerers (aka Jackals)...on the Yahoo Finance board...well..they are back, but just a little...

Bringing up that Earnings report will be awful...a Reverse Split is coming (they've used that one for many months)...no Future earnings...

Menace212

Menace212 6 분 전

Lol ain’t that the truth

Viewmont

Viewmont 6 분 전

Too bad! There's no rhyme or logic.

boywonder1

boywonder1 6 분 전

The only blunder and scumbag is you!!! You are a worthless p0s but you already know that! You deserve nothing and are nothing! Go to he@@. I have ridden this up 3 times now biotch! I have made money and will make more a$$hole!!! Be more original twat!EMGE$$$__$$$$

Jackxkr

Jackxkr 7 분 전

JJ also soent 650 grand two years ago on shares at.85 a share . I am not sure I would be using him as a temperature gauge. Why would Malik sell at .38?
Now mgmt us foung the exact opposite of what they should be doing. These prople are afflicted with alligator arms and can't reach their wall

Ms Labonte

Ms Labonte 7 분 전

Going much higher $weet$$

JJZander

JJZander 7 분 전

When u can’t beat em, join em

Rodney5

Rodney5 7 분 전

FORM 10-Q quarterly period ended June 30, 2024

Amounts attributable to senior preferred stock (2,760) The company did not use the term dividend. Page 48

Net income per common share $0.00

INTRODUCTION: Net worth was $53.2 billion as of June 30, 2024, up f

JakBqk

JakBqk 7 분 전

So, how many weeks has past without any dilution ? I'm not sure exactly ,I lost count. Can someone provide this information please? I'm starting to feel a little bit bullish, .....a little bit 😂..unless you tell me he's (Henry) been at it again

Paulness

Paulness 7 분 전

NEWS -- Theriva™ Biologics Receives Rare Pediatric Drug Designation by the U.S. FDA for VCN-01 for the Treatment of Retinoblastoma

https://media.zenfs.com/en/globenewswire.com/66da9d5d384dea69bc442e7797b7b48a

ROCKVILLE, Md., July 31, 2024 (GLOBE NEWSWIRE) -- Theriva™ Bi

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관